Smoking tobacco is associated with renal hyperfiltration

References

• Ueyama C, Horibe H, Yamase Y, et al. Association of smoking with prevalence of common diseases and metabolic abnormalities in community-dwelling japanese individuals. Biomed Rep. 2017;7(5):429–438.
   PubMed Web of Science ®Google Scholar
• Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic effects of smoking. Chest. 2007;131(5):1557–1566.
   PubMed Web of Science ®Google Scholar
• WHO. global report on trends in prevalence of tobacco use 2000-2025 third edition [Internet]. Geneva: World Health Organization 2019. Available from: https://www.who.int/publications/i/item/who-global-report-on-trends-in-prevalence-of-tobacco-use-2000-2025-third-edition.
   Google Scholar
• Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2224–2260.
   PubMed Web of Science ®Google Scholar
• Orth SR. Cigarette smoking: an important renal risk factor - far beyond carcinogenesis. Tob Induc Dis. 2002;1(2):137–155.
   PubMedGoogle Scholar
• Shankar A, Klein R, Klein BEK. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol. 2006;164(3):263–271.
   PubMed Web of Science ®Google Scholar
• Gambaro G, Verlato F, Budakovic A, et al. Renal impairment in chronic cigarette smokers. JASN. 1998;9(4):562–567.
   Web of Science ®Google Scholar
• Yamagata K, Ishida K, Sairenchi T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71(2):159–166.
   PubMed Web of Science ®Google Scholar
• Janssen WM, Hillege H, Pinto-Sietsma SJ, PREVEND Study Group. Prevention of Renal and Vascular End-stage Disease, et al. Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population. Clin Chem Lab Med. 2000;38(11):1107–1110.
   PubMed Web of Science ®Google Scholar
• Hall ME, Wang W, Okhomina V, et al. Cigarette smoking and chronic kidney disease in African Americans in the Jackson heart study. J Am Heart Assoc. 2016;5(6):e003202
   Web of Science ®Google Scholar
• Yoon HJ, Park M, Yoon H, et al. The differential effect of cigarette smoking on glomerular filtration rate and proteinuria in an apparently healthy population. Hypertens Res. 2009;32(3):214–219.
   PubMed Web of Science ®Google Scholar
• Hammer Y, Cohen E, Levi A, et al. The relationship between cigarette smoking and renal function: a large cohort study. Isr Med Assoc J. 2016;18:553–556.
   PubMed Web of Science ®Google Scholar
• Halimi JM, Giraudeau B, Vol S, et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int. 2000;58(3):1285–1292.
   PubMed Web of Science ®Google Scholar
• Maeda I, Hayashi T, Sato KK, et al. Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men. Clin J Am Soc Nephrol. 2011;6(10):2462–2469.
   PubMed Web of Science ®Google Scholar
• Noborisaka Y, Honda R, Ishizaki M, et al. Alcohol and cigarette consumption, renal function and blood pressure in middle-aged healthy men. J Hum Hypertens. 2007;21(12):966–968.
   PubMed Web of Science ®Google Scholar
• Dupuis ME, Nadeau-Fredette AC, Madore F, et al. Association of glomerular hyperfiltration and cardiovascular risk in middle-aged healthy individuals. JAMA Netw Open. 2020;3(4):e202377.
   PubMed Web of Science ®Google Scholar
• Eriksen BO, Løchen ML, Arntzen KA, et al. Subclinical cardiovascular disease is associated with a high glomerular filtration rate in the nondiabetic general population. Kidney Int. 2014;86(1):146–153.
   PubMed Web of Science ®Google Scholar
• Ogna A, Forni Ogna V, Bochud M, et al. Association between obesity and glomerular hyperfiltration: the confounding effect of smoking and sodium and protein intakes. Eur J Nutr. 2016;55(3):1089–1097.
   PubMed Web of Science ®Google Scholar
• Moriya T, Tanaka S, Sone H, et al. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan diabetes complications study. J Diabetes Complications. 2017;31(2):473–478.
   PubMed Web of Science ®Google Scholar
• Hong S, Choi YM, Ihm S-H, et al. Association between metabolic parameters and glomerular hyperfiltration in a representative korean population without chronic kidney disease. PLoS One. 2018;13(12):e0207843.
   PubMed Web of Science ®Google Scholar
• Ekberg G, Grefberg N, Larsson LO, et al. Cigarette smoking and glomerular filtration rate in insulin-treated diabetics without manifest nephropathy. J Intern Med. 1990;228(3):211–217.
   PubMed Web of Science ®Google Scholar
• Ekblom K, Marklund SL, Jansson JH, et al. Iron stores and HFE genotypes are not related to increased risk of first-time myocardial infarction: a prospective nested case-referent study. Int J Cardiol. 2011;150(2):169–172.
   PubMed Web of Science ®Google Scholar
• Ljungberg J, Johansson B, Bergdahl IA, et al. Mild impairment of renal function (shrunken pore syndrome) is associated with increased risk for future surgery for aortic stenosis. Scand J Clin Lab Invest. 2019;79(7):524–530.
   PubMed Web of Science ®Google Scholar
• Pukkala E, Andersen A, Berglund G, et al. Nordic biological specimen banks as basis for studies of cancer causes and control-more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol. 2007;46(3):286–307.
   PubMed Web of Science ®Google Scholar
• Norberg M, Wall S, Boman K, et al. The Vasterbotten intervention programme: background, design and implications. Global Health Action. 2010;3(1):4643.
   PubMed Web of Science ®Google Scholar
• Eriksson M, Holmgren L, Janlert U, et al. Large improvements in major cardiovascular risk factors in the population of Northern Sweden: the MONICA study 1986-2009. J Intern Med. 2011;269(2):219–231.
   PubMed Web of Science ®Google Scholar
• Ljungberg J, Johansson B, Engström KG, et al. Traditional cardiovascular risk factors and their relation to future surgery for valvular heart disease or ascending aortic disease: a case-referent study. JAHA. 2017;6(5):e005133.
   Web of Science ®Google Scholar
• Björk J, Grubb A, Sterner G, et al. Revised equations for estimating glomerular filtration rate based on the Lund-Malmö study cohort. Scand J Clin Lab Invest. 2011;71(3):232–239.
   PubMed Web of Science ®Google Scholar
• Nyman U, Grubb A, Larsson A, et al. The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population. Clin Chem Lab Med. 2014;52:815–824.
   PubMed Web of Science ®Google Scholar
• Grubb A, Horio M, Hansson LO, et al. Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator. Clin Chem. 2014;60(7):974–986.
   PubMed Web of Science ®Google Scholar
• Palatini P. Glomerular hyperfiltration: a marker of early renal damage in pre-diabetes and pre-hypertension. Nephrol Dial Transplant. 2012;27(5):1708–1714.
   PubMed Web of Science ®Google Scholar
• Cachat F, Combescure C, Cauderay M, et al. A systematic review of glomerular hyperfiltration assessment and definition in the medical literature. CJASN. 2015;10(3):382–389.
   PubMed Web of Science ®Google Scholar
• Grubb A. Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options. Clin Biochem. 2020;83:12–20.
   PubMed Web of Science ®Google Scholar
• Åkesson A, Lindström V, Nyman U, et al. Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities. Scand J Clin Lab Invest. 2020;80(5):412–422.
   PubMed Web of Science ®Google Scholar
• Almén MS, Björk J, Nyman U, et al. Shrunken pore syndrome is associated with increased levels of atherosclerosis-promoting proteins. Kidney Int Rep. 2019;4(1):67–79.
   PubMed Web of Science ®Google Scholar
• Söderström EB, Wennberg R, Andersson P, et al. Mild impairment of renal function (shrunken pore syndrome) is associated with increased risk of a future first-ever myocardial infarction in women. Scand J Clin Lab Invest. 2021;81(6):438–445.
   PubMed Web of Science ®Google Scholar
• Peralta CA, Shlipak MG, Judd S, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA. 2011;305(15):1545–1552.
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Matsushita K, Ärnlöv J, CKD Prognosis Consortium, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369(10):932–943.
   PubMed Web of Science ®Google Scholar
• Nerpin E, Ingelsson E, Risérus U, et al. The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men. Nephrol Dial Transplant. 2011;26(9):2820–2827.
   PubMed Web of Science ®Google Scholar
• Husain SA, Willey JZ, Park Moon Y, et al. Creatinine- versus cystatin C-based renal function assessment in the Northern manhattan study. PLoS One. 2018;13(11):e0206839.
   PubMed Web of Science ®Google Scholar
• Cheuiche AV, Queiroz M, Azeredo-da-Silva ALF, et al. Performance of cystatin C-Based equations for estimation of glomerular filtration rate in diabetes patients: a prisma-compliant systematic review and meta-analysis. Sci Rep. 2019;9(1):1418.
   PubMed Web of Science ®Google Scholar
• Mathisen UD, Melsom T, Ingebretsen OC, et al. Estimated GFR associates with cardiovascular risk factors independently of measured GFR. JASN. 2011;22(5):927–937.
   Web of Science ®Google Scholar
• Melsom T, Fuskevåg OM, Mathisen UD, et al. Estimated GFR is biased by non-traditional cardiovascular risk factors. Am J Nephrol. 2015;41(1):7–15.
   PubMed Web of Science ®Google Scholar
• Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009;75(6):652–660.
   PubMed Web of Science ®Google Scholar
• Sundin PO, Sjöström P, Jones I, et al. Measured glomerular filtration rate does not improve prediction of mortality by cystatin C and creatinine. Nephrol Dial Transplant. 2017;32(4):663–670.
   PubMed Web of Science ®Google Scholar
• Halimi JM, Philippon C, Mimran A. Contrasting renal effects of nicotine in smokers and non-smokers. Nephrol Dial Transplant. 1998;13(4):940–944.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Jacob P, 3rd, Yu L. Daily use of smokeless tobacco: systemic effects. Ann Intern Med. 1989;111(2):112–116.
   PubMed Web of Science ®Google Scholar
• Norberg M, Blomstedt Y, Lönnberg G, et al. Community participation and sustainability-evidence over 25 years in the Västerbotten Intervention Programme. Glob Health Action. 2012;5:1–9.
   PubMed Web of Science ®Google Scholar